Today: 4 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp shares jumped 7.2% to $244.13 Monday after Bank of America raised its price target to $250, maintaining a Neutral rating. The move followed volatile trading after earnings and comes as investors focus on AI-driven optical demand and upcoming U.S. inflation data. Other optical stocks also gained. Coherent forecast third-quarter revenue of $1.70–$1.84 billion and non-GAAP EPS of $1.28–$1.48.
Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital shares jumped 9.6% to $38.32 Monday afternoon, swinging between $33.48 and $39.33 on heavy volume. No new company news was posted. About a third of the float was sold short as of mid-January, heightening volatility. Traders are eyeing U.S. payrolls and CPI data later this week for further market direction.
Philip Morris (PM) stock price slips today despite fresh target hikes as Zyn battle stays in view

Philip Morris (PM) stock price slips today despite fresh target hikes as Zyn battle stays in view

Philip Morris International shares fell 1.4% to $180.17 in Monday afternoon trading after a new debt shelf filing and recent earnings guidance. Investors focused on competition in nicotine pouches and upcoming U.S. economic data. The stock traded between $179.85 and $182.54, about 1.6% below its 52-week high. Several analysts raised their price targets following the company’s updated 2026 outlook.
9 February 2026
Arrowhead Pharmaceuticals stock swings as S&P MidCap 400 move lands and Goldman flags 2026 catalysts (ARWR)

Arrowhead Pharmaceuticals stock swings as S&P MidCap 400 move lands and Goldman flags 2026 catalysts (ARWR)

Arrowhead Pharmaceuticals shares fell 0.7% to $64.10 in afternoon trading Monday after moving from the S&P SmallCap 600 to the S&P MidCap 400. The stock saw heavy volume and a wide intraday range. Goldman Sachs maintained a Neutral rating and $85 target, citing key 2026 pipeline data and competition from Ionis Pharmaceuticals. Arrowhead recently reported Q1 revenue of $264 million and 22 cents EPS.
Microchip stock drops on $600 million convertible-notes plan — what investors watch next

Microchip stock drops on $600 million convertible-notes plan — what investors watch next

Microchip Technology shares fell about 2% to $74.52 after the company announced a $600 million convertible notes offering. Proceeds will fund capped-call hedges and repay commercial paper borrowings. The notes mature in 2030 and will be sold privately to institutional buyers. Traders are watching for final pricing and hedging flows that could move the stock.
9 February 2026
Merck stock drops nearly 4%: why MRK is lagging the market today

Merck stock drops nearly 4%: why MRK is lagging the market today

Merck shares fell 3.9% to $117.16 Monday, underperforming the broader market as investors weighed patent risks and 2026 earnings guidance. Amgen, Pfizer, and AbbVie also declined. Merck last week projected 2026 sales of up to $67 billion and warned of a $2.5 billion hit from generic competition and weaker COVID-19 drug sales. The Dow lagged as Merck and Amgen dragged on the index.
Intuit stock drops in afternoon trade as TD Cowen cuts target and AI jitters linger

Intuit stock drops in afternoon trade as TD Cowen cuts target and AI jitters linger

Intuit shares fell 1.3% to $438.01 Monday, underperforming a 2.4% gain in the broader software sector. TD Cowen cut its price target to $658, citing AI concerns, while Jefferies maintained an $850 target, calling AI fears “too harsh.” The stock traded between $431.53 and $447.00. Investors are watching for Intuit’s quarterly results on Feb. 26.
Palo Alto Networks stock jumps as Nasdaq sets a close date for the CyberArk deal

Palo Alto Networks stock jumps as Nasdaq sets a close date for the CyberArk deal

Palo Alto Networks shares rose 3.4% to $164.81 Monday after Nasdaq set a tentative Feb. 11 closing date for its $25 billion CyberArk merger. CyberArk shares gained 4% to $407.38, with trading set to halt after-hours Feb. 10. The deal gives CyberArk holders $45 cash and 2.2005 Palo Alto shares per share. Investors await Palo Alto’s quarterly results on Feb. 17 for updates on integration and demand.
Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher shares rose 0.1% to $543.48 Monday after the company filed for a four-part senior notes offering to help fund its planned Clario acquisition. The preliminary prospectus left key terms blank and showed $39.38 billion in consolidated debt as of Dec. 31, 2025. S&P rated the proposed debt ‘A-’. Executive Gianluca Pettiti filed to sell 400 shares valued at $216,480.
9 February 2026
AST SpaceMobile stock (ASTS) whipsaws in New York trade as the next satellite milestone nears

AST SpaceMobile stock (ASTS) whipsaws in New York trade as the next satellite milestone nears

AST SpaceMobile shares fell 0.5% to $101.28 by 2:13 p.m. EST after swinging between $98.95 and $108.25 in volatile trading. The move came as broader U.S. markets rose and investors awaited updates on the BlueBird 7 satellite launch, now scheduled for no earlier than late February. Blue Origin will handle the launch from Cape Canaveral. The company still needs more regulatory approvals and capital for its planned 2026 rollout.
9 February 2026
Boeing stock ticks up after Air Force C-17 upgrade award, with BA in focus ahead of jobs, CPI

Boeing stock ticks up after Air Force C-17 upgrade award, with BA in focus ahead of jobs, CPI

Boeing shares rose 0.4% to $243.98 Monday after announcing a U.S. Air Force contract to modernize the C-17A flight deck. Curtiss-Wright said Boeing picked it to supply mission computers for the upgrade, valuing its contract at over $400 million. The Pentagon listed Boeing’s deal at $266.6 million, with work through 2031. Traders are watching U.S. jobs and inflation data later this week.
9 February 2026
Why Constellation Energy (CEG) stock is up today: new 380‑MW Texas data center deal

Why Constellation Energy (CEG) stock is up today: new 380‑MW Texas data center deal

Constellation Energy shares rose 3.6% to $270.81 after its Calpine unit signed a 380-MW power deal with CyrusOne for a new Texas data center. The agreement lifts CyrusOne’s contracted power in Texas above 1,100 MW. Constellation also announced a 20-year energy contract for the Tennessee Titans’ new stadium. Vistra, NRG, and Talen Energy shares also gained.
9 February 2026
P&G stock slides while Wall Street rises — what investors are watching this week

P&G stock slides while Wall Street rises — what investors are watching this week

Procter & Gamble shares fell 1.2% to $157.24 in Monday afternoon trading, underperforming the broader market as consumer-staples stocks weakened. Investors are awaiting U.S. jobs and inflation data due later this week. P&G’s last update showed flat sales and profit, with volume declines in key segments. The company declared a quarterly dividend of $1.0568 per share, payable Feb. 17.
9 February 2026
1 60 61 62 63 64 685
Go toTop